Interestingly, DNMT3B may act as a tumor suppressor in certain subtypes of AML, such as MLL-AF9 AML and inv (16) (p13;q22) AML, highlighting a complex role in leukemia development [116]. Here, KMT2A is linked to acute myeloid leukemia.